International Patients
Pourquoi nous choisir?
ELZA, une combinaison unique de chirurgiens hautement qualifiés, de physiciennes, et de chercheurs. Ensemble, ils garantissent un traitement optimal.
APPRENEZ PLUS
لماذا نحن؟
مؤسسة «الزا» في سويسرا تضم نخبة مميزة من اطباء عيون متمرسين, فيزيائيين, وباحثين, لكي تزودك بالعلاج الامثل.
اعرف اكثر
با انتخاب ما از چه مزایایی می توانید بهره مند شوید؟
موسسه الزا در کشور سوئیس شامل مجموعه ای از متبحترین چشم پزشکان، متخصصان فیزیک و پژوهشگران می باشد تا بهترین راه حل را برای درمان مشکل شما فراهم نمایند.
طلاعات بیشتر
Почему Вам лучше выбрать нас?
ELZA Institute в Швейцарии – это уникальное сочетание высококвалифицированных офтальмологов, физиков и научных исследователей, которые готовы предоставить Вам самoе лучшее лечение.
УЗНАЙТЕ БОЛЬШЕ
Latest News
Awards and Distinctions
Given to ELZA members in the past 20 years for their contributions in ophthalmology.
Scientific
Our research laboratory at the University of Zurich
The ELZA co-founder Prof. Farhad Hafezi is running a research laboratory at the University of Zurich, Switzerland. The main foci are corneal biomechanics (keratoconus) and ocular cell biology.
Visit the CABMM’s website here.
Educational
We proudly announce that the second edition of our medical textbook “Corneal Cross-Linking” will soon appear with Slack Inc. The book is edited by ELZA Founder Farhad Hafezi (University of Geneva & USC Los Angeles) and J. Bradley Randleman (USC Los Angeles). It is the oldest and most complete international textbook on cross-linking technology.
Humanitarian
Our International humanitarian initiative
To increase awareness about keratoconus in children.
To disseminate information amongst parents and children.
To treat children with keratoconus in National Reference Sites.
To perform research to identify the causes of keratoconus.
Visit the Light for Sight website here.
Entrepreneurial
ELZA in the global “Top 40 under 40”
We are proud to announce that our co-founder and head of Strategy and BD&L, Nikki Hafezi, MASIP ETHZ, was voted by her peers among the Top 40 under 40 in the British journal “The Ophthalmologist. This list comprises “the most important upcoming personalities in global opthalmology“.
Mrs Hafezi also serves as CEO of EMAGine SA.
See the online version of the PowerList “Top 40 under 40” here, and read the PDF here.
Developing the future of Cross-Linking Technology
ELZA members co-founded a Spin-Off Company: EMAGine SA.
EMAGine SA develops a cross-linking device that will fit on a slit lamp.
The device will allow for treatment outside an operating theatre.
Visit EMAGine’s website here.
ELZA Posts
Screening at the Expat Expo 2017 – Dietikon
Light for Sight Foundation conducts free screenings for keratoconus Dietikon, Switzerland – On Sunday, September 3, 2017 the Light for ...
More...
More...
SmILE biomechanically more solid than flap-based laser surgery
SmILE provides a biomechanically more solid residual cornea than flap-based approaches. SmILE more solid than flap-based refractive laser surgery: this ...
More...
More...
Our new Research Laboratory at USC Roski Eye Institute
New Research Laboratory for Ocular Cell Biology and Biomechanics at the USC Roski Eye Institute After 4 years of preparation, ...
More...
More...
A new algorithm to predict the Cross-Linking effect
New algorithm predicts CXL effect and might help to treat keratoconus corneas thinner than 400 µm. Algorithm predicts CXL effect: ...
More...
More...
Why perform corneal cross-linking at the slit lamp?
CXL at the slit lamp may provide access to all. Cataract & Refractive Surgery Today Europe April 2017: ELZA member and ...
More...
More...
ELZA at 2017 Meeting of Polish Ophthalmological Society
Annual Meeting of the Polish Ophthalmological Society 2017 The ELZA founder Farhad Hafezi gives an invited lecture on "Past, Present ...
More...
More...
Categories
Video Interviews
-
Awards
-
Scientific Publications
-
Popular Press
-
Podium Power
-
Search News
